Клиническая микробиология и антимикробная химиотерапия
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
About the journal
Клиническая микробиология и антимикробная химиотерапия is an open-access journal published by Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
- ISSN
- 1684-4386 · 2686-9586
- Country
- Russia
- Languages
- russian
- Access
- Open access
- Articles in DOAJ
- 471
- Declared review time
- 8 weeks
- Declared peer-review model
- double_blind
- Official website
- https://cmac-journal.ru/en/
Index listings
- DOAJ · 2019-10-25
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
471
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
393
Last recorded publication year
2025
h-index
16
i10-index
31
From OpenAlex open data (CC0).
Editorial & policy8
- Last DOAJ review date
- 2021-04-10
- Added to DOAJ
- 2019-10-25
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 35%
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- KMAHClinical microbiology and antimicrobial chemotherapy
- Source type
- journal
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Bacterial Identification and Susceptibility Testing
- Bacterial Identification and Susceptibility Testing
Show all subjects (75)
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
- Bacterial Identification and Susceptibility Testing
- Pneumonia and Respiratory Infections
- Antibiotics Pharmacokinetics and Efficacy
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- Antifungal resistance and susceptibility
- Bacterial biofilms and quorum sensing
- Bacterial biofilms and quorum sensing
- Infections and bacterial resistance
- Antifungal resistance and susceptibility
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Microbial infections and disease research
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Nosocomial Infections in ICU
- Nosocomial Infections in ICU
- Urinary Tract Infections Management
- Reproductive tract infections research
- Reproductive tract infections research
- COVID-19 Clinical Research Studies
- Bacterial biofilms and quorum sensing
- Streptococcal Infections and Treatments
- Streptococcal Infections and Treatments
- Bacterial Infections and Vaccines
- Nosocomial Infections in ICU
- Tuberculosis Research and Epidemiology
- Sepsis Diagnosis and Treatment
- Tuberculosis Research and Epidemiology
- Infection Control in Healthcare
- Mycobacterium research and diagnosis
- Bacterial Infections and Vaccines
- Bacterial Infections and Vaccines
- Mycobacterium research and diagnosis
- Infective Endocarditis Diagnosis and Management
- Clostridium difficile and Clostridium perfringens research
- Clostridium difficile and Clostridium perfringens research
- Fungal Infections and Studies
- Infective Endocarditis Diagnosis and Management
- Reproductive tract infections research
- Helicobacter pylori-related gastroenterology studies
- Fungal Infections and Studies
- Fungal Infections and Studies
- Helicobacter pylori-related gastroenterology studies
- Mycobacterium research and diagnosis
- Respiratory viral infections research
- Respiratory viral infections research
- Tuberculosis Research and Epidemiology
- Syphilis Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Yersinia bacterium, plague, ectoparasites research
- Yersinia bacterium, plague, ectoparasites research
- Syphilis Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Gut microbiota and health
- Gut microbiota and health
- Gut microbiota and health
- Probiotics and Fermented Foods
- Helicobacter pylori-related gastroenterology studies
- Surgical site infection prevention
- Salmonella and Campylobacter epidemiology
Keywords (DOAJ)
- antibiotics
- epidemiology
- antimicrobial resistance
- surveillance
- infection diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ